Gov. Gavin Newsom, state lawmakers, and health industry leaders have a small window to reach an agreement on billions of new dollars for Medi-Cal before it’s put to voters in November.
For biotechs in the industry’s handful of hot areas, it’s a seller’s market
A radiopharma company purchased for more than three times the price of its IPO from a few months earlier. Neuroscience companies driving up their offers
January 27, 2024